- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks
U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
7
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
7 companies
Diaceutics
Market Cap: UK£116.3m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.38
7D
3.0%
1Y
15.5%
ECO Animal Health Group
Market Cap: UK£50.1m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.74
7D
-0.7%
1Y
-26.4%
Ovoca Bio
Market Cap: UK£938.0k
A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.
OVB
UK£0.011
7D
0%
1Y
39.4%
Futura Medical
Market Cap: UK£28.4m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.093
7D
-25.2%
1Y
-72.1%
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-82.0%
Cizzle Biotechnology Holdings
Market Cap: UK£5.5m
Develops an immunoassay test for the CIZ1B, a non-invasive diagnostic tool for the early detection of lung cancer in the United Kingdom.
CIZ
UK£0.014
7D
-9.7%
1Y
-17.6%
Arecor Therapeutics
Market Cap: UK£24.0m
A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.
AREC
UK£0.64
7D
11.4%
1Y
-30.6%